Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
58.22 USD | +0.57% | -9.61% | -29.33% |
05-09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
05-08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |